Director, Companion Diagnostic Program Manager

At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.

Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.

Does this inspire you and feel like a fit? Then we would love to have you join us!

As a Director, Companion Diagnostic Program Manager, you will be part of the Program Management function and will be responsible for providing strategic and operational leadership for the planning, development, validation, and execution of companion diagnostic assays (CDx) projects across our oncology portfolio.

The role leads CDx sub-teams, in partnership with CDx SMEs to ensure that the CDx strategy (where applicable) is effectively integrated into Compound Development Plan and Target Product Profile. This position is responsible for delivering compliant, high-quality diagnostic solutions aligned with clinical development timelines and regulatory expectations.

You will report to the Head of Program Management and work closely with colleagues from Translational & Quantitative Sciences (including the Companion Diagnostic expert team), Clinical Strategy, Regulatory, Commercial, Market Access and external diagnostic collaborators.

• Lead development of CDx strategy for oncology programs from early through late-stage development and global Health Authority approvals in partnership with CDx SMEs, who will represent the CDx sub team on Compound Development Team.
• Providing strategic guidance and driving cross-functional alignment for programs requiring predictive biomarkers.
• Provide strategic and operational leadership for the development and execution of integrated CDx plans supporting patient selection, therapeutic assessment, regulatory approval and commercial viability of CDx assays, in partnership with CDx SMEs.
• Ensure CDx timelines and deliverables are aligned with clinical development milestones, regulatory submissions, and commercialization plans.
• Present CDx strategy, progress and results to senior leadership, governance committees, and external stakeholders in collaboration with CDx SMEs.
• Lead preparation of presentations to governance committee to support decision-making related to diagnostic strategy, execution, and vendor selection.
• Oversee external diagnostic partnerships in collaboration with Alliance Management, including scope definition, performance oversight, risk management, issue resolution, budget accountability, and working with Joint Steering Committee members.
• Partner with CDTL/ PM of the compound, Clinical Strategy, Precision Medicine, Regulatory Affairs, and Quality functions to ensure alignment with protocol, regulatory, and operational requirements.
• Support inspection readiness and participate in internal and external audits, including regulatory inspections and partner audits.

• Bachelor’s degree in Biological Sciences, Bioengineering or a related field, with a minimum of 10 years of experience in diagnostics, pharmaceuticals, or the life sciences industry.
• Seven or more years of experience in project…